The P. caribaeorum n-hexane extract (21.0 g) was initially fractionated over silica gel CC (108 g) using as the elution solvent n-hexane, n-hexane/EtOAc 4:1, 3:2, 2:3, 1:4, EtOAc and, finally, MeOH. The n-hexane/EtOAc 4:1 fraction (3.6 g), a white amorphous precipitate, was purified by addition of MeOH followed by filtration to yield campesterol 1 (3.0 g). The n-hexane/EtOAc 3:2 fraction (0.9 g) was subjected to silica gel CC by elution with n-hexane/EtOAc gradient (7:3 → 0:10) and then with MeOH to give 6 fractions (F1-F6) after TLC analysis. F2 (230.8 mg), obtained by elution with n-hexane/EtOAc 4:1, was rechromatographed over silica gel using an isocratic mixture of CH 2 Cl 2 /EtOAc 7:3 to yield 32 subfractions of 8 mL each, from which F2(4-5), a white amorphous powder, was identified as 5α,8α-epi-dioxycampesterol 2 (15.9 mg). The n-hexane/EtOAc 2:3 fraction (1.1 g) was subjected to silica gel CC by elution with n-hexane/EtOAc gradient (5:5 → 0:10) followed by MeOH to afford 3 main fractions (F1-F3), after TLC analysis. F2 (676.9 mg), obtained by elution with n-hexane/EtOAc 4:6, was subjected to silica gel CC using n-hexane/EtOAc gradient (8:2 → 0:10) followed by MeOH to yield 6 subfractions [F2(1) to F2(6)] after TLC analysis. F2(3), a white amorphous powder, was identified as 7α-hydroxycampesterol 3 3 (39.1 mg).
2
The P. caribaeorum EtOH extract (61.7 g), suspended in MeOH/H 2 O 7:3 (250 mL) was partitioned with CH 2 Cl 2 and then with EtOAc (3 × 250 mL of each solvent). Both CH 2 Cl 2 and EtOAc fractions were evaporated under reduced pressure to yield 11.6 and 3.6 g, respectively. The CH 2 Cl 2 fraction (11.6 g) was subjected to successive silica gel CC eluted with a gradient of n-hexane/EtOAc (3:7  0:10) to yield a white amorphous powder identified as 24(R)-ergost-7-en-3β,5α,6β-triol 4 (29.9 mg).
The P. variabilis n-hexane extract (19.8 g) was fractionated over a silica gel CC by elution with n-hexane, n-hexane/CH 2 Cl 2 1:1, CH 2 Cl 2 , CH 2 Cl 2 /EtOAc 1:1, EtOAc, and, finally, MeOH. The n-hexane/CH 2 Cl 2 1:1 and CH 2 Cl 2 fractions were combined (9.4 g) and subjected to successive silica gel CC eluted with n-hexane/EtOAc gradients to yield campesterol 1 (6.3 g). The CH 2 Cl 2 /EtOAc 1:1 fraction (4.3 g) was subjected to silica gel CC using a gradient of n-hexane/EtOAc (7:3 → 0:10) followed by MeOH to yield 6 sub-fractions (F1-F6), after TLC analysis. F2 (723.6) afforded a mixture of 1-hexadecylglicerol and 7α-hydroxycampesterol 3 3 (57.4 mg) after washing with n-hexane/EtOAc 1:1. F3 (537.0 mg) was subjected to silica gel CC by elution with n-hexane, CH 2 Cl 2, and finally EtOAc to give 5α,8α-epi-dioxycampesterol 2 (21.3 mg) after elution with n-hexane/EtOAc 4:6.
GC-MS analysis of the n-hexane fractions from P. caribaeorum and P. variabilis GC-MS analysis was carried out on a Shimadzu GCMS-QP2010-Plus spectrometer using a capillary column RTx-5 (30 m × 0.25 mm i.d., 0.25 µm film thickness), He as carrier gas, flow rate of 1.7 mL min -1 and split mode (ratio 1:48). Both injector and detector temperatures were 250 and 280 °C, respectively. The column temperature was programmed from 40 to 180 °C for 48 min and then from 180 to 250 °C for 20 min, and held isothermally for 7 min.
An aliquot of each sample (200 mg) was submitted to esterification reaction with KOH/EtOH 2N. The unsaponifiable material was extracted with CH 2 Cl 2 and further subjected to CC over silica gel eluting with n-hexane/EtOAc (9:1 and 7:3), and then with pure EtOAc. The n-hexane/EtOAc 7:3 fraction rich in palysterols, was subjected to GC-MS analysis (Table S2 and Figures S1-S20). Figure S20 . GC analyses of steroids from P. caribaeorum and P. variabilis. Table S1 . 13 C NMR data comparison of 24(R)-7α-hydroperoxy-ergost-5-en-3β-ol (1) with 7α-hydroperoxycholesterol (1a) and 7β-hydroperoxycholesterol (1b), and 6β-carboxyl-24(R)-(8→6)abeo-ergostan-3β,5β-diol (2) with B-nor-ergostan-3β,5β-diol-6β-carboxyl acid (2a) 
